MX2014015253A - Forma de dosificacion efervescente. - Google Patents

Forma de dosificacion efervescente.

Info

Publication number
MX2014015253A
MX2014015253A MX2014015253A MX2014015253A MX2014015253A MX 2014015253 A MX2014015253 A MX 2014015253A MX 2014015253 A MX2014015253 A MX 2014015253A MX 2014015253 A MX2014015253 A MX 2014015253A MX 2014015253 A MX2014015253 A MX 2014015253A
Authority
MX
Mexico
Prior art keywords
dosage form
effervescent
agent
effervescent dosage
acid
Prior art date
Application number
MX2014015253A
Other languages
English (en)
Other versions
MX368363B (es
Inventor
Mark Edward Stella
John Richard Entwisle
Jason William Newlon
Christine Louie Naykki
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2014015253A publication Critical patent/MX2014015253A/es
Publication of MX368363B publication Critical patent/MX368363B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una forma de dosificación masticable efervescente que comprende un agente de neutralización de pH, un ácido, y un agente efervescente. La forma de dosificación masticable puede comprender, además, simeticona, un edulcorante, y un lubricante. El agente de neutralización de pH puede ser carbonato de calcio, el ácido puede ser ácido cítrico y el agente efervescente puede ser bicarbonato de sodio.
MX2014015253A 2012-06-12 2013-06-12 Forma de dosificacion efervescente. MX368363B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261658430P 2012-06-12 2012-06-12
PCT/US2013/045303 WO2013188483A1 (en) 2012-06-12 2013-06-12 Effervescent dosage form

Publications (2)

Publication Number Publication Date
MX2014015253A true MX2014015253A (es) 2015-03-05
MX368363B MX368363B (es) 2019-09-30

Family

ID=48672843

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014015253A MX368363B (es) 2012-06-12 2013-06-12 Forma de dosificacion efervescente.

Country Status (12)

Country Link
US (1) US10617714B2 (es)
EP (1) EP2734192B1 (es)
CN (1) CN104363897A (es)
AU (1) AU2013274378B2 (es)
BR (1) BR112014030680B1 (es)
CA (1) CA2876062C (es)
ES (1) ES2541723T3 (es)
IN (1) IN2014DN10385A (es)
MX (1) MX368363B (es)
PL (1) PL2734192T3 (es)
RU (1) RU2014149581A (es)
WO (1) WO2013188483A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2604124A1 (en) * 2011-12-16 2013-06-19 Nestec S.A. Soluble non-dairy creamer tablet surface-treated with carbohydrate
US20180168995A1 (en) * 2015-06-29 2018-06-21 Elc Man Llc Particles With Cross-Linked Coatings For Cosmetic Applications
CN107114795A (zh) * 2017-07-06 2017-09-01 胥永贵 一种弱碱补钙、苏打碱化姜制剂及其制备方法和应用
US11793876B2 (en) 2019-10-18 2023-10-24 L. Perrigo Company Bulk polyethylene glycol compositions
WO2022060310A1 (en) * 2020-09-18 2022-03-24 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising calcium carbonate, magnesium carbonat and simethicone
US20230013964A1 (en) * 2021-06-17 2023-01-19 Ocean Spray Cranberries, Inc. Rare Sugars in Food and Beverage Products

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1518364A (en) 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4198390A (en) 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4396604A (en) 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
GB2148117B (en) 1983-09-28 1987-10-21 Gergely Gerhard An effervescent composition suitable for effervescent tablets
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4650669A (en) 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5073384A (en) 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
DE59203732D1 (de) 1991-07-01 1995-10-26 Gergely Gerhard Lutsch- oder Kautablette.
AU4597293A (en) 1992-06-30 1994-01-24 Procter & Gamble Company, The Effervescent calcium supplements
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
FR2705966B1 (fr) 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
ATE188376T1 (de) 1995-07-31 2000-01-15 Gerhard Gergely Kautablette mit brausewirkung
CN1167436A (zh) 1995-09-07 1997-12-10 大制药株式会社 低压泡滕片剂
US5807577A (en) 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5888544A (en) 1996-06-20 1999-03-30 Gerhard Gergely Effervescent system for effervescent tablets and effervescent granules
DE19814256A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
DE19859231A1 (de) 1998-12-21 2000-06-29 Kurt Heinz Bauer Schäumende Antacida-Suspensionstabletten
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US20030235613A1 (en) 2002-06-19 2003-12-25 Cts Chemical Industries Ltd. Popping oral administration form
US20040223921A1 (en) 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US20050074489A1 (en) 2003-10-01 2005-04-07 Pediamed Pharmaceuticals, Inc. Effervescent and effervescent-dispersion compositions for medicaments and methods of use thereof
ITMI20040242U1 (it) 2004-05-24 2004-08-24 Istituto Pirri S R L Contenitore per compresse effervescenti
WO2006044595A2 (en) 2004-10-13 2006-04-27 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
EP2189154A1 (en) 2008-11-25 2010-05-26 Gnosis S.p.A. Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
CN101966165B (zh) 2009-07-14 2012-06-13 无锡健而乐医药科技有限公司 口腔吸收固体泡腾制剂
WO2011113965A1 (es) 2010-03-18 2011-09-22 Farmalider, S.A. Composición farmacéutica en forma sólida que contiene isoflavonas, una sal de calcio y vitamina d3
CN102232967A (zh) * 2010-04-21 2011-11-09 武汉同济现代医药有限公司 一种新型口服补钙泡腾剂及其制备方法
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form

Also Published As

Publication number Publication date
AU2013274378A1 (en) 2015-01-15
CA2876062A1 (en) 2013-12-19
BR112014030680A2 (pt) 2017-06-27
US20190262392A1 (en) 2019-08-29
EP2734192B1 (en) 2015-04-15
MX368363B (es) 2019-09-30
ES2541723T3 (es) 2015-07-24
BR112014030680B1 (pt) 2022-08-30
CN104363897A (zh) 2015-02-18
AU2013274378B2 (en) 2016-06-02
PL2734192T3 (pl) 2015-09-30
EP2734192A1 (en) 2014-05-28
WO2013188483A1 (en) 2013-12-19
RU2014149581A (ru) 2016-07-10
IN2014DN10385A (es) 2015-08-14
US10617714B2 (en) 2020-04-14
CA2876062C (en) 2017-09-12

Similar Documents

Publication Publication Date Title
MX368363B (es) Forma de dosificacion efervescente.
PH12014501213B1 (en) Aqueous oral care compositions
MX2016001424A (es) Composiciones edulcorantes.
MX2015016676A (es) Soluciones orales estables para api combinados.
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
GB201215159D0 (en) Composition
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
PE20161498A1 (es) Composicion reactiva basada en bicarbonato de sodio y procedimiento para su produccion
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
PH12015501250A1 (en) Oral care compositions comprising calcium carbonate and a preservative system based on benzyl alcohol or benzoic acid, and an alkylene glycol
AR100452A1 (es) Composiciones dentífricas que tienen conservantes optimizados
WO2013006766A3 (en) Formulations that stabilize proteins
WO2014144407A8 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
MX2017007622A (es) Composiciones para el cuidado bucal.
MX2017009659A (es) Composiciones que contienen arsenico y su uso en metodos de tratamiento.
PH12017501603A1 (en) Solid oral care composition
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.
TR201005241A1 (tr) Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
UA79245U (ru) Лечебный гель для глаз "таугель"
MX2008015058A (es) Formulaciones de sal de prednisolona.
UA81786U (en) Nonalcoholic drink "lypova fantazia" (lime phantasy)
AR086153A1 (es) Aditivo para pre-enjuague final de maquinas lavadoras de botellas
RO130486A8 (ro) Formulă farmaceutică pentru comprimate masticabile mentolate cu calciu şi vitamina d3
IN2014MU01326A (es)

Legal Events

Date Code Title Description
FG Grant or registration